Finland· FI-REL-REL60723

Trilocur

A trilostaani product containing trilostane, registered in Finland by Emdoka. The same ATC class is registered in 2 of our 19 countries.

ATC QH02CA01

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedTrilocurATCQH02CA01REGISTER NO.FI-REL-REL60723PACKS LISTED0CHECKEDSeptember 27, 2026

Where it is registered

Trilostane is registered in 2 of 19 countries.

Countries holding a registration under ATC QH02CA01 (trilostaani), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 1 of them publish a price we can compare per daily dose

Trilostane · ATC QH02CA01

2 / 19 countries

  • Denmark
  • Finlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Trilostane
Manufacturer
Emdoka
Country
Finland (FI)
ATC code
QH02CA01
ATC class
Trilostaani
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Trilostane in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All trilostane products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d4849ad6-6b85-4fdc-924c-a732c1efe35f
GET /v1/drugs/d4849ad6-6b85-4fdc-924c-a732c1efe35f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "oraalisuspensio",
  "route": "Suun kautta",
  "ddd_unit": null,
  "strength": "50 mg/ml",
  "atc_label": "Trilostaani",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/2/24/312/003-008",
  "fimea_rel_id": "REL60723",
  "authorised_at": "2024-05-06"
}

See everything about trilostane.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.